company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10739935.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10739935.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,863725.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,863725.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9876210.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1811701.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5848123.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1034800.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,171726.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8866350.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1009860.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,405956.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,50334.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-355622.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,654238.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,374461.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,279777.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,279777.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7527.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,287304.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20445560.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21207645.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28700000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:15:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12190870.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12190870.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,909434.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,909434.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11281436.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1834844.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5692048.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1138955.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,171732.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8837579.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2443857.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,547795.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,48675.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-499120.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1944737.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,943141.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1001596.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1001596.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-6648.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1008244.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20327867.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20803182.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20200000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 17:01:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10666927.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10666927.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,786938.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,786938.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9879989.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2002004.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5288584.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1009673.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,171727.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8471988.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1408001.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,216043.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,42909.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-173134.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1234867.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,523584.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,711283.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,711283.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9877.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,721160.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20445921.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20777666.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18000000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 17:18:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14389741.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14389741.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1283160.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1283160.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13106581.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2371506.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5904444.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1027048.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,171726.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9474724.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3631857.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,79604.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52260.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27344.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3604513.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1436365.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2168148.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2168148.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9471.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2177619.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20471621.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20661719.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19800000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 17:17:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13054278.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13054278.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1341256.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1341256.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11713022.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2149364.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5060546.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1233025.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,171727.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8614662.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3098360.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,33390.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52459.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,19069.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3117429.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1278472.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1838957.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1838957.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-8455.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1847412.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20327537.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20534647.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20500000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q3,2011-07-01,2011-09-30,2012-11-02 17:00:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12782848.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,248982.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13031830.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1951200.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1951200.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11080630.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2784427.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4686486.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1758326.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,140122.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9369361.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1711269.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24460.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,63099.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,38639.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1749908.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,841783.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,908125.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,908125.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-3540.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,911665.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20342913.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20572132.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20200000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10256212.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10256212.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,848550.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,848550.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9407662.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2265025.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4980553.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1404022.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,112047.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8761647.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,646015.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22427.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72281.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,49854.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,695869.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,282028.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,413841.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,413841.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9367.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,423208.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20007998.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20234438.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21200000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 21:28:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12366940.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12366940.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1103005.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1103005.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11263935.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2147518.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5491964.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1553343.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,131179.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9324004.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1939931.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16720.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,76074.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,59354.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1999285.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,263031.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1736254.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1736254.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-8036.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1744290.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19771167.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19996805.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19400000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 17:07:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12531719.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12531719.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,921862.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,921862.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11609857.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1890849.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4914551.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1696592.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,128702.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8630694.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2979163.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17222.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,107719.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,90497.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3069660.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1207504.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1862156.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1862156.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7338.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1869494.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19432715.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19670741.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18700000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q3,2012-07-01,2012-09-30,2013-11-06 17:09:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12789160.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,907206.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13696366.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2172762.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2172762.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11523604.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2752567.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4942425.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,441215.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,134404.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8270611.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3252993.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15616.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,48791.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,33175.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3286168.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1492213.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1793955.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1793955.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11545.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1805500.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19564625.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19787537.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19500000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10258132.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10258132.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1108635.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1108635.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9149497.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2575739.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3673939.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1448718.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,125050.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7823446.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1326051.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17735.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,92377.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,74642.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1400693.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,559367.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,841326.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,841326.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13383.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,854709.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18758383.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18925165.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17100000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:07:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7081088.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7081088.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1154833.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1154833.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5926255.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1855201.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3542049.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1386904.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,282645.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7066799.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1140544.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20700.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,48982.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28282.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1112262.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-463408.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-648854.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-648854.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9836.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-639018.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18405522.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18405522.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 17:03:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6528575.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6528575.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1030943.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1030943.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5497632.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1958629.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3410205.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1440584.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,202982.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7012400.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1514768.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24286.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20350.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3936.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1518704.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-686209.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-832495.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-832495.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-12553.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-819942.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18233407.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18233407.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20500000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 17:01:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7232903.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,926764.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8159667.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2145011.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2145011.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6014656.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3100407.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3761552.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1339295.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,285479.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8486733.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2472077.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,40701.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68582.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27881.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2444196.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-932801.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1511395.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1511395.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11032.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1500363.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18332997.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18332997.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19100000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8093244.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8093244.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1053717.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1053717.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7039527.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1897217.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3613931.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,826373.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,293955.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6631476.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,408051.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12203.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,67343.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,55140.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,463191.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,188009.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,275182.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,275182.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11138.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,286320.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17907848.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18161680.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14300000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q1,2014-01-01,2014-03-31,2015-05-15 17:03:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9750168.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9750168.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1298816.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1298816.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8451352.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2140249.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3930082.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,861154.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,304258.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7235743.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1215609.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12278.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29544.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,17266.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1232875.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,523339.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,709536.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,709536.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13034.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,722570.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17743395.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18025913.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18100000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 17:06:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9729047.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9729047.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1339723.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1339723.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8389324.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2158057.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3821953.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,934783.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,485493.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7400286.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,989038.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26877.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,108005.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,81128.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1070166.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,340982.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,729184.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,729184.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-16736.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,745920.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17544905.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17848110.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18600000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 17:12:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9111303.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,218109.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9329412.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1360909.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1360909.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7968503.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2206037.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3536236.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,767109.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,516294.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7025676.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,946138.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15716.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,46555.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,30839.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,976977.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,328414.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,648563.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,648563.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-20350.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,668913.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17617765.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17899632.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17300000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8686774.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8686774.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1161841.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1161841.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7524933.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1644141.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3530915.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1859012.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,486749.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7520817.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4116.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15550.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,56402.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,40852.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,44968.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18456.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26512.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26512.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-19769.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,46281.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17012852.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17405019.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q1,2015-01-01,2015-03-31,2016-05-13 16:52:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8909741.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8909741.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1237001.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1237001.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7672740.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2153562.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3505486.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,828070.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,511691.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6998809.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,673931.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18489.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,57846.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,39357.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,713288.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,318990.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,394298.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,394298.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11700.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,405998.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16820725.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17184345.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20300000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:05:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7885048.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7885048.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,980176.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,980176.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6904872.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1794279.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3608828.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,757442.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,473439.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6633988.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,270884.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19815.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64072.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,44257.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,315141.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,193439.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,121702.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,121702.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4911.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,126613.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16604682.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16996376.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12700000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 17:17:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7531621.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,505867.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8037488.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1589152.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1589152.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6448336.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2015606.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3349539.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,403127.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,517385.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6285657.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,162679.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20002.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,30863.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10861.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,173540.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,44944.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,128596.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,128596.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-23863.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,152459.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16715970.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17094754.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18300000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7737532.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7737532.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1223939.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1223939.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6513593.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2077972.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3698962.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,706472.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,530770.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7014176.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-500583.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20442.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,77129.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,56687.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-443896.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-175339.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-268557.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-268557.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-15446.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-253111.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16341481.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16341481.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12700000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q1,2016-01-01,2016-03-31,2017-05-15 16:59:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7414835.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7414835.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1155261.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1155261.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6259574.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1874396.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3272279.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,678780.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,539428.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6364883.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-105309.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,28247.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31483.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3236.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-102073.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-41135.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60938.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60938.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-12894.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-48044.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16247028.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16247028.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:01:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8791753.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8791753.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1973948.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1973948.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6817805.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1865575.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3614714.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,644662.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,562722.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6687673.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,130132.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29088.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,51636.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,22548.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,152680.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,57192.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,95488.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,95488.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-10678.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,106166.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16217442.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16504568.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10600000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 17:12:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9081440.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9081440.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1605512.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1605512.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7475928.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2743868.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3967526.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1160786.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,561119.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8433299.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-957371.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,28615.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44413.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,15798.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-941573.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-171642.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-769931.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-769931.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-20237.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-749694.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16236525.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16236525.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15700000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9636755.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9636755.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1381497.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1381497.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8255258.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2110233.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5293020.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,898363.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,611444.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8913060.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-657802.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,31715.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52535.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,20820.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-636982.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,656587.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1293569.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1293569.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-19123.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1274446.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16042219.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16042219.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15900000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 17:13:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8667127.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8667127.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1668926.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1668926.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6998201.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2353140.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4654933.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1080426.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,590573.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8679072.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1680871.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,30029.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,69481.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,39452.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1641419.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3535783.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5177202.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5177202.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-16591.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5160611.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16011758.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16011758.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16100000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q2,2017-04-01,2017-06-30,2018-08-14 17:12:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11196961.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11196961.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2166353.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2166353.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9030608.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2090785.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6226438.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,943162.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,609572.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9869957.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-839349.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8902.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,94833.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,85931.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-753418.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3822.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-757240.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-757240.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-14209.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-743031.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15867159.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15867159.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14900000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q3,2017-07-01,2017-09-30,2018-11-14 17:16:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11649288.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11649288.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2153809.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2153809.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9495479.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3097192.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5318546.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1358434.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,624633.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10398805.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-903326.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22258.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,82477.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,60219.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-843107.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-21303.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-821804.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-821804.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-21259.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-800545.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15911577.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15911577.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16000000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8587605.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8587605.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1527961.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1527961.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7059644.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2330281.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4670511.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1874939.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,636135.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9511866.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2452222.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18302.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,82494.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,64192.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2388030.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4159.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2392189.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2392189.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-12950.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2379239.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15689240.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15689240.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15900000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q1,2018-01-01,2018-03-31,2019-05-15 17:12:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10163724.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10163724.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1523319.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1523319.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8640405.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2334223.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5076250.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1450390.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,648520.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9509383.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-868978.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22019.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,149706.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,127687.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-741291.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4159.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-745450.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-745450.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-24762.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-720688.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15674954.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15674954.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14400000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q2,2018-04-01,2018-06-30,2019-08-14 17:28:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8492530.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8492530.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1460463.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1460463.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7032067.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2067981.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4803112.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1306055.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,661802.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8838950.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1806883.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19199.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,166220.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,147021.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1659862.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4159.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1664021.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1664021.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-20977.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1643044.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15573108.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15573108.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14900000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q3,2018-07-01,2018-09-30,2019-11-13 17:19:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13497906.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13497906.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2866352.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2866352.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10631554.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3418292.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5708434.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2944508.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,823009.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12894243.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2262689.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,136328.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,166064.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29736.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2232953.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4159.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2237112.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2237112.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-17015.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2220097.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15614052.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15614052.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15500000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8729860.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8729860.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1658789.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1658789.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7071071.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2536739.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3436932.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1399687.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1021645.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8395003.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1323932.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,60911.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,115861.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,54950.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1268982.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-81428.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1187554.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1147136.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40418.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,33460.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-73878.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15472952.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15891570.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q1,2019-01-01,2019-03-31,2020-05-22 17:13:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11580600.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11580600.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2012196.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2012196.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9568404.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2528916.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5153129.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1458366.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1029708.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10170119.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-601715.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,91200.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,130565.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,39365.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-562350.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4462.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-566812.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-566812.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-17305.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-549507.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15523628.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15523628.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13700000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q2,2019-04-01,2019-06-30,2019-08-14 17:28:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10371918.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10371918.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1921875.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1921875.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8450043.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2422886.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5562443.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1278013.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1033786.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10297128.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1847085.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,64877.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-50511.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-115388.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1962473.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4462.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1966935.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1966935.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13267.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1953668.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15368027.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15368027.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15000000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q3,2019-07-01,2019-09-30,2019-11-13 17:19:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16851259.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16851259.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3159160.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3159160.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13692099.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2873892.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7276536.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2342526.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1049418.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13542372.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,149727.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29198.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,47449.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,18251.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,167978.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6812.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,174790.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1147136.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-972346.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-11640.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-960706.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15396098.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15396098.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15400000.0
Cumberland Pharmaceuticals Inc,CPIX,,0001087294,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
